Cantargia AB 2023 SR
The report highlights Cantargia's commitment to sustainable pharmaceutical development for cancer and inflammatory diseases. In 2023, the company focused on climate impact mitigation, tracking energy use, water consumption, and travel emissions, which totaled 19,739 kg CO2. The company aligns its operations with several UN Sustainable Development Goals and emphasizes social responsibility through fair wages and diversity. Governance is maintained through a Code of Conduct and transparency in decision-making.
Company: Cantargia AB
Sector: Professional & technical services
Country: Sweden
Year: 2023
Type: SR
Pages: 5
Back to company
Cantargia AB
Sustainability Report
The report highlights Cantargia's commitment to sustainable pharmaceutical development for cancer and inflammatory diseases. In 2023, the company focused on climate impact mitigation, tracking energy use, water consumption, and travel emissions, which totaled 19,739 kg CO2. The company aligns its operations with several UN Sustainable Development Goals and emphasizes social responsibility through fair wages and diversity. Governance is maintained through a Code of Conduct and transparency in decision-making.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Women on Board
Women in Management
Employees